NGF acts as a neurotrophic
factor by binding and activating its receptor on certain neuronal populations in the CNS and PNS. TrkA is a receptor for NGF. Recent findings in vitro indicate that this NGF-activated receptor tyrosine kinase transduces the NGF signal. To further define NGF actions in the CNS, we examined trk?i expression in the adult rat brain. We found that trkA mRNA and immunoreactivity (IR) coincided in specific, defined neuronal populations in the forebrain and brainstem. In addition to cholinergic neurons in the basal forebrain and neostriatum, trkA expression was found in noncholinergic neurons in (1) the paraventricular anterior and reuniens thalamic nuclei, (2) the rostra1 and intermediate subnuclei of the interpeduncular nucleus (IPN), (3) scattered neurons in the ventrolateral and paramedian medulla, (4) the prepositus hypoglossal nucleus, and (5) the area postrema.
NGF responsiveness was demonstrated for each of these populations. In contrast to trkA, ~75~~~~ was found only in a minority of NGFresponsive populations.
Our data provide further evidence that expression of trlrA marks NGF-responsive CNS neurons and suggests novel roles for NGF in the brain.
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The neurotrophins are structurally related polypeptides that make up one family of neurotrophic factors (Thoenen, 1991) . NGF is the best characterized member of this family which includes brain derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and NT-4/5 (Thoenen, 1991; Chao, 1992) . NGF plays a critical role in the survival and maintenance of dorsal root ganglion and sympathetic neurons in the developing and adult PNS (Johnson and Gorin, 1980; Levi-Montalcini, 1987; Longo et al., 1992) . NGF also acts on neostriatal and basal forebrain cholinergic neurons in the developing and mature CNS and may serve as a trophic factor for these cells (for review, see Longo et al., 1992) .
NGF signals by binding to and activating specific cell surface receptors. As is the case for the other neurotrophins, NGF binds to p7YGFR (Johnson et al., 1986; Radeke et al., 1987) , a transmembrane glycoprotein, and to a receptor tyrosine kinase of the trk gene family. TrkA is the receptor for NGR trkB for BDNF and NT4/5, and trkC for NT-3 (Klein et al., 1990; Kaplan et al., 1991; Lamballe et al., 1991; Meakin and Shooter, 1991) . NGF binding to trkA results in dimerization and autophosphorylation on tyrosine residues with resultant activation of signaling (Kaplan et al., 1991b; Jing et al., 1992) . Studies in cell lines transfected with members of the trk gene family indicate that activation of a trk transduces neurotrophin signaling (Cordon-Card0 et al., 1991; Loeb et al., 1991; Zhou et al., 1994) . Under certain conditions and depending on cellular context, ~75~~~~ appears capable of facilitating trk activation (Verdi et al. 1994) . Interestingly, ~75~~~~ knockout mice have abnormalities of the PNS (Lee et al., 1992) , and trigeminal sensory neurons from these animals have an altered dose response to NGF (Davies et al, 1993) . While this suggests that ~75~~"~ modulates neurotrophin signaling in at least some neuronal populations, its exact role remains to be defined. Taken together, these observations indicate that trk expression is key to neurotrophin responsiveness and suggest that localization of trk expression can be used further to define the biological functions of NGF and other neurotrophins. These findings may be relevant to disease states in which the interaction of a neurotrophin with its receptor may be implicated in either pathophysiology or treatment.
While localization of trk expression is an important clue to neurotrophin responsiveness, it is insufficient to prove the case. This is due in part, to the existence-of truncated isoforms of both trkB and trkC that lack a tyrosine kinase domain and to nonsignaling isoforms of trkC (Klein et al., 1990; Tsoulfas et al., 1993; Valenzuela et al., 1993) . To date, only two trkA isoforms have been discovered and each contains the kinase domain and signals in response to NGF binding (Barker et al., 1993) . However, it is conceivable that coexpression of trkA with truncated isoforms of trkB or trkC could diminish signaling through trkA or that other factors could negatively modulate signaling. These considerations emphasize that while localization of trk mRNAs and proteins can help to suggest neurotrophin targets, it is essential to demonstrate a neurotrophin response in the neurons thus identified.
Many studies have now shown that basal forebrain and neostriatal cholinergic neurons are NGF responsive (Gnahn et al., 1983; Hefti et al., 1985; Mobley et al., 1985; Hagg et al., 1989; Higgins et al., 1989) . It has been shown that trkA is expressed in these neurons (Holtzman et al., 1992b; Steininger et al., 1993) . Moreover, in vitro and in vivo studies have shown that NGF rapidly induces phosphorylation of trkA in these cells (Knusel et al., 1992; Knusel et al., 1994) . Widespread localization of NGF mRNA and protein in the CNS suggested that there existed other NGF-responsive populations (Large et al., 1986; Whittemore et al., 1986) . Recently, several other CNS neuronal populations have been reported to express trkA mRNA (Merlio et al., 1992; Venero and Hefti, 1993) . However, it is uncertain as to whether these, or perhaps other CNS neurons expiess trkA protein and respond to NGE Herein, we document trkA expression in nine CNS neuronal populations in seven brain regions. Significantly, we show that each population is able to respond to NGE These results suggest novel trophic roles for NGF in the adult mammalian brain.
Materials and Methods
Anitnul preparation and NGF injection. Female Sprague-Dawley rats (3-6 month old) were used for all studies. For trkA expression studies, eight animals were used for in situ hybridization histochemistry (ISHH) and eight for immunocytochemistry. Rats were deeply anesthetized (Holtzman et al., 1992a ) and perfused transcardially with 60 ml of PBS (pH 7.4, 4°C) followed by 200 ml of 4% (wt/vol) paraformaldehyde in 0. I M sodium phosphate (pH 7.4, 4°C). Brains were removed, postfixed overnight in the same fixative, and then dehydrated in 20% wt/vol sucrose in 0.1 M sodium phosphate (pH 7.4, 4°C). They were then frozen in powdered dry ice and stored at -70°C. For NGF studies, animals received a 14 d infusion of mouse NGF (Mobley et al., 1986 ) dissolved in vehicle (artificial CSE N = 3) or the vehicle alone (N = 3) into the right lateral ventricle (Holtzman et al., 1993) . Composition of artificial CSF was as follows: 150 mM NaCI, 3.0 mM KCl,-1.4 mM CaCI,, 0.8 mM MgCI,. 1 mM Na,HPO,-NaH,PO,. Surgical orocedures were oerformed"ex&ly as des&ibed~Holt~man, et a [, 1963 ) with the follo\;ing modifications: (1) Alzet model 2002 miniosmotic pumps (Alza Corp., Palo Alto, CA) were used; (2) cannula placement was 0.2 mm anterior to bregma, 1.1 mm lateral to the midline, and 5.0 mm ventral to the skull surface; and (3) flow rate was 0.5 p,lihr (1.25 pg NGF/hr = 30 pg NGF/24 hr).
In situ hybridization histochemistry (ISHH) and immunocytochemistry. Thirty micrometer coronal sections (for ISHH) or 40 p,m coronal sections (for immunocytochemistry) were cut on a freezing sliding microtome and collected in 0.1 M Tris-buffered saline (TBS, pH 7.6, 4°C). Serial sections were examined from the olfactory bulb rostrally through the entire medulla caudally. For ISHH, sections were mounted on Siperfrost plus slides (Fisher Scientific, Springfield, NJ) and allowed to dry overnight. They were then stored at -70°C prior to ISHH. ISHH was carried out using RNA probes under stringent conditions exactly as described (Cunningham and De Souza, 1993) . Probes were labeled with either S'5-UTP (1225 Ci/mmol) or P13-UTP (1700 Ci/mmol) (Du Pont, New England Nuclear, Boston, MA). TrkA sense and antisense riboprobes were generated from pDM97 (gift of L. Parada), a plasmid containing a 434 bp mouse trkA cDNA cloned into pGEM-7Zf (Promega, Madison, WI) (Holtzman et al., 1992b) . The insert corresponds to a portion of the extracellular domain of mouse trkA and is specific for trkA.
Immunocytochemistry for trkA, ChAT, and ~75~~~~ were performed as described (Holtzman et al., 1992a,b) . In these experiments, omission of the primary antibody resulted in no staining in any brain region. The antibody to trkA (RTA, used at l/4000) is specific for t&A. It was raised in rabbits to the baculovirus expressed extracellular domain of rat trkA. On antigen blots, it recognizes trkA but does not recognize either trkB or trkC (Clary et al., 1994) . NADPH-d histochemistry was performed as described (Ferriero et al., 1988) . In colocalization studies, NADPH-d staining was performed on sections which were first immunostained for trkA.
Trk phosphorylation assay. Sixteen adult female Sprague-Dawley rats were anesthetized (Holtzman et al., 1992a) and brains were removed and placed in cold PBS (pH 7.4, 4°C). The septal region was dissected as described (Johnston et al., 1987) . A dissecting microscope was used to visualize the midline ventral mesencephalon (containing the IPN). Two fine tweezers were used to remove the overlying meninges and blood vessels and then a square pi ece of tissue (-2 X 2 mm) lying within the interpeduncular fossa was removed. Tissue from each region was then cut into pieces -0.5 X 0.5 mm using microdissecting scissors. The tissue from the septal region or midline ventral mesencephalon from I6 animals was then separated into four groups (N = 4 per group) and triturated 10X with a glass pipette tip (-500 km) and then 10X with a fire-polished glass pipette tip (-150 pm). This procedure produced individual cells and cell clusters. Tissue from each brain region was then collected into a 1.5 ml Eppendorf tube and incubated with NGF (100 rig/ml) in vehicle (Hanks BSS, pH 7.4) or in vehicle alone at 37°C for 5 min. Immunoprecipitation and antigen blotting were performed as described previously (Kaplan et al., 1991b; Zhou et al., 1994) . Tissue was lysed in lysis buffer (20 mM Tris HCI pH 8.0; 150 mM NaCl; 1% NP40; 10% glycerol; 1 mM sodium orthovanadate; I mu PMSF; 10 mg/ml benzamidine; 1 mg/ml o-phenanthroline; 0.1 mg/ml each pepstatin, chymostatin, leupeptin, and aprotinin). Immunoprecipitation was performed with an anti-pan-trk antibody (1088) overnight at 4°C (Zhou et al., 1994) . 1088 binds to all full-length trks. Immunoprecipitates were collected using protein A/Sepharose beads (Pierce, Rockford, IL) and were subjected to 7.5% SDS-PAGE, prior to transfer to nitrocellulose and immunoblotting using an antibody to phosphotyrosine 4GlO (UBI, Lake Placid, NY). Assessment of t&A-IR neuronal profiles. Measurement of the crosssectional area of t&A-IR profiles in different brain regions was performed with the MCID image analysis system (Imaging-Research, Inc., St. Catherines, Ontario) linked to a Leitz Aristoolan microscooe (Leica, Inc., Foster City, CA) as described (Holtzman et al., 1993) . dells were visualized utilizing a 40X objective, and the area of every trkA-IR neuronal profile with a nucleus was assessed. Cell size assessment included measurements in the medial septal nucleus, the neostriatum, the paraventricular anterior nucleus of the thalamus, the rostra1 subnucleus of the IPN, the prepositus hypoglossal nucleus, the area postrema, and the paragigantocellular reticular region in the medulla. For each animal, one to three coronal sections in each brain region were examined. Every trkA-IR neuron in the medial septal nucl eus were measured in one section (0.20 mm anterior to bregma) if it was superior to a line between the anterior commissures and within 0.75 mm of the midline. All trkA-IR neurons from both sides of the neostriatum from the same section were also examined. TrkA-IR neurons in the paraventricular nucleus of the thalamus were measured in three adjacent sections 1 mm posterior to bregma. All IR-cells were within 0.5 mm of the midline. For the rostra1 subnucleus of the IPN, three adjacent sections at the level shown in Figure 3A (5.8 mm caudal to bregma) were assessed. TrkA-IR neurons in the prepositus hypoglossal n;cleus from three adjacent sections 12.0 mm caudal to bregma were measured. For the area postrema and the paragigantocellular reticular nucleus, t&A-IR neurons from three adjacent sections 12.8 mm caudal to bregma were measured. For the paragigantocellular reticular nucleus, all t&A-IR neurons lateral to the inferior olivary complex and not more than 1.2 mm dorsal to the ventral surface of the medulla were measured.
Results
TrkA is localized to several neuronal populations In situ hybridization (ISHH) and immunocytochemistry were used to define cells containing trkA mRNA and protein in the CNS. Previous studies documented the restricted distribution of trkA expression in the CNS; they showed that essentially all cholinergic neurons in the basal forebrain and neostriatum contain trkA mRNA (Holtzman et al., 1992b) and are immunoreactive (IR) for trkA protein (Steininger et al., 1993) . Utilizing a trkA-specific riboprobe and a trkA-specific antibody (RTA), trkA expression was readily detected in neurons in the basal forebrain ( Fig. IA-C) and neostriatum ( Fig. ID-F) . All trkA-IR cell bodies in the these regions conformed in their distribution and size to cholinergic neurons. TrkA expressing basal forebrain cholinergic neurons are known to project widely to hippocampus and neocortex. TrkA-IR fibers were found in these regions and are likely to reflect the presence of trkA on the surface of axons originating in the basal forebrain. TrkA expressing striatal cholinergic neurons are interneurons whose processes extend TrkA containing neurons in the medial septal nucleus are in the same distribution as that seen for ChAT containing neurons (Holtzman et al., 1992b) . D-F are adjacent coronal sections 0.20 mm anterior to bregma (centered 4 mm lateral to the midline) demonstrating trkA expression in large cholinergic intemeurons in the striatum. G-l are coronal sections 1 mm posterior to bregma. In these sections, rrkA expression is seen in small neurons in the paraventricular thalamic nucleus, anterior. These sections are at the same level as plates 17 and 22 of a rat brain atlas (Paxinos and Watson, 1986) . All panels are at the same magnification. Scale bar, 120 pm. throughout the striatum. Consistent with this pattern was the diffuse trkA-IR found throughout the striatal neuropil (Fig. 1E) .
Localization studies revealed several additional populations in the CNS that contained both trkA mRNA and protein. In the diencephalon, populations adjacent to the midline in the anterior paraventricular and reuniens thalamic nuclei expressed trkA (Fig. lG-I ). In the brainstem, several specific neuronal populations in the midbrain, pons, and medulla also expressed trkA. In the ventral midbrain, trkA mRNA and IR were present in subnuclei of the interpeduncular nucleus (see next section). In the pons and medulla, trkA mRNA and IR were seen in large neurons in the prepositus hypoglossal nucleus ( Fig. 2A-C) and in small neurons in the area postrema (Fig. 2D-F) . In the area postrema, cells along the rim consistently appeared to contain more trkA mRNA than cells located in the core; however, trkA immunostaining revealed trkA-IR neurons throughout the nucleus. TrkA expression was also seen in scattered large neurons in the ventral and paramedian medulla (Fig. 2G-I) . Most of these neurons were located between the inferior olivary complex and the lateral reticular nucleus, an ill-defined region referred to as the gigantocellular and paragigantocellular reticular nuclei (Paxinos and Watson, 1986) . A few trkA-IR neurons were also seen within the boundaries of the lateral reticular nucleus (data not shown), although these were similar in size and shape to IR soma in the contiguous reticular formation. Two brainstem nuclei displayed evidence of trkA-IR cell bodies but by ISHH, showed no evidence of synthesizing trkA mRNA: the dorsal nucleus of the lateral lemniscus and the ventral cochlear nucleus. There was no evidence of trkA expressing cell bodies in the cerebellum.
T&A was expressed in the interpeduncular nucleus
The interpeduncular nucleus (IPN) is located in the ventral midline of the midbrain in all mammals. Because of anatomical and neurochemical inhomogeneity, the nucleus has been divided into several subnuclei (Fig. 3 ) . TrkA mRNA and IR were localized to neurons with cell bodies exclusively within the rostra1 and intermediate subnuclei (Figs.  4A,B ; 5). Together these two subnuclei comprise 55% of the volume of the IPN. The IPN contains the largest concentration of ACh (Kasa, 1986) and ChAT activity of any brain region studied (Palkovits et al., 1974) . ACh in the IPN is present in cholinergic axons and nerve terminals. The cholinergic innervation of the IPN predominantly arises from the thalamic medial habenular nuclei and is conveyed to the subnuclei of the IPN in the fasciculus retroflexus, a prominent fiber bundle (Lenn et al., 1985) . No neurons in the habenular complex expressed trkA (data not shown). While there are dense cholinergic terminals in the IPN, there were no cholinergic cell bodies intrinsic to this nucleus ( Fig. 4E ) (Lenn et al., 1985) . TrkA-IR neurons in the Although there appears to be more trkA mRNA in neurons around the rim of the area postrema, MA-IR is present in neurons in both the rim and the core. G-l are adjacent coronal sections through the ventrolateral medulla centered 1.5 mm to the right of the midline (-12.8 mm caudal to bregma). TrkA mRNA and IR are present in large neurons just lateral to the inferior olivary complex. These neurons are in regions referred to as the paragigantocellular and gigantocellular reticular nuclei. The sections in this figure are at the same level as Figures 66 (A-C) , 69 (G-I), and 72 (D-F) in the rat brain atlas of Paxinos and Watson (1986) . All panels are at the same magnification. Scale bar, 120 pm.
IPN were small to medium sized (Fig. 6A, Table 1 ). Prior studies suggest that these cells are likely to be cholinoceptive (Lenn et al., 1985) . p7YGFR-IR was not detected in t&A-expressing IPN neurons (Fig. 40) . Nitric oxide synthase containing neurons, which are NADPH-diaphorase positive, and trkA-IR neurons have overlapping areas of distribution in both the rostra1 and intermediate subnuclei. However, trkA-IR and NADPH-d activity were not obviously colocalized in double stained sections in the IPN (data not shown).
NGF induced t&A activation
We asked whether trkA expression in IPN neurons was sufficient to confer NGF-signaling in these cells. NGF receptor activation induces autophosphorylation of t&A on tyrosine, a property that has been demonstrated both in vivo and in vitro (Kaplan et al., 1991 (Kaplan et al., , 1991b Knusel et al., 1994) . To determine whether IPN neurons would respond to NGF dissociated cells from the septal region (containing basal forebrain cholinergic neurons) or the medial portion of the ventral midbrain (containing the IPN) were exposed to NGF or the vehicle control for 5 min at 37°C. Cells were then lysed and trk proteins were immunoprecipitated with an anti-pan-trk antibody and analyzed by SDS-PAGE. For immunoblotting, we used an antibody to phosphotyrosine. Since NGF interacts specifically with trkA but not with trkI3 or trkC, any increase in phosphotyrosine on trk proteins due to NGF treatment should represent NGF-induced tyrosine phosphorylation on trkA. NGF treatment induced tyrosine phosphorylation of a 125 kDa protein in both septal and IPN dissociates (Fig. 7) . This band appears to correspond to trkA because it was cross-reactive with RTA on antigen blots (data not shown). Thus, probably due to differences in glycosylation, the molecular weight of trkA in the CNS appears slightly less than that seen in PC1 2 cells (140 kDa). Interestingly, on a per milligram protein basis, the amount of t&A-associated tyrosine phosphate as a result of NGF treatment was greater in the IPN than in the septum (Fig. 7) .
NGF acted on all trkA expressing CNS neuronal populations Neuronal hypertrophy was among the first actions described for NGF (Levi-Montalcini, 1987; Longo et al., 1992) and has been seen in every NGF-responsive population examined to date. To determine whether NGF would activate signaling in trkA expressing CNS neurons, we asked whether NGF would induce hypertrophy in these cells. NGF was infused into the lateral ventricle of adult rats for 2 weeks. Artificial CSF served as the vehicle control. Following NGF administration, there was no discernable increase in the staining density of trkA-IR cell pro- Hamill and Lenn (1984) , Lenn and Hamill (1984) , and Groenewegen et al. (1986) .
The Journal of Neuroscience, Februaty 1995, f5 (2) 1571 files in any of the populations assessed. Cross-sectional area of trkA-IR profiles containing nuclei was measured in all neuronal populations containing t&A mRNA and IR. The mean crodssectional area was uniformly increased in NGF-treated subjects. The increase ranged from 15-28% (Table 1) . In all cases, the increases were statistically significant (Table 1) . The degree of hypertrophy in the newly defined trkA-IR neuronal profiles was equivalent to that seen for profiles of basal forebrain and neostriatal cholinergic neurons. Thus, robust NGF actions were recorded in all trkA expressing CNS neuronal populations. Evidence that NGF affected most if not all trkA-IR neurons within each population comes from analysis of neuronal profile distributions. The size distribution of trkA-IR profiles were normal (not skewed) in each forebrain and brainstem region examined in both NGF-and vehicle-treated subjects. In NGF-treated brains, the entire distribution of sizes were shifted to the right. In striatal trkA-IR neurons, we also assessed the mean crosssectional area of nuclei. NGF increased this measure by 19% (NGF = 56.8 p,rn2 + 1.5, IZ = 275, N = 3; VEH = 47.8 pm* f 1.4, n = 258; p < 0.0001).
To establish that the effect of NGF was specific for trkAexpressing neurons, we examined neostriatal neurons which stain for NADPH-d. These cells do not contain trkA-IR. Cell size was measured in NGF and vehicle treated animals. NGF infusion did not affect the size of these neurons (NGF = 120.5 pm* +-2.5, n = 351, N = 3; VEH = 120.4 ? 2.6, n = 340, N = 3; p = 0.95). Figure   3A . A, ISHH reveals ?rkA mRNA expression in the rostra1 subnucleus (dark-field photomicrograph). B, Same section stained with H and E (brightfield photomicrograph).
C, Immunostaining reveals that t&A-IR in small neurons in the rostra1 subnucleus. In D, immunostaining for p7YFR gives no evidence for either cell body or fiber staining in this region. E, Immunostaining for Cl-&T shows abundant ChAT-IR fibers; these originate predominantly in the medial habenula. Scale bar, 120 pm. All panels are the same magnification. Figure 3A . A, t&A-IR is seen in a subpopulation of small neurons in the rostra1 subnucleus. B, Adjacent section stained with cresyl violet. C and D, At the level of the IPN just caudal to Figure  3B . C, t&A-IR is seen in a subpopulation of medium sized neurons in the intermediate subnuclei (bilateral) and the single rostra1 subnucleus (midline). D, Adjacent section stained with cresyl violet. Scale bar, 120 pm. All panels are the same magnification.
Discussion
The major findings in this study are (1) the discovery of novel trkA expressing NGF-responsive neurons in five brain regions and (2) that NGF responsiveness correlates withtrkA expression in the CNS. In addition to basal forebrain and neostriatal cholinergic neurons, NGF-responsive neurons were found in the (1) paraventricular anterior and reuniens thalamic nuclei, (2) rostra1 and intermediate subnuclei of the interpeduncular nucleus, (3) prepositus hypoglossal nucleus, (4) area postrema, and (5) ventrolateral medulla. The data confirm that trkA plays a critical role in NGF signaling and raise the possibility that NGF acts as a trophic factor for the newly defined neuronal populations, contributing to their development and normal mature function.
The use of a t&A-specific riboprobe and antibody allowed us to detect potential NGF-responsive neuronal populations. Our studies give data which both complement and contrast with findings in earlier studies. There is agreement that t&A mRNA and protein (Holtzman et al., 1992b; Steininger et al., 1993) as well as specific NGF binding (Richardson et al., 1986; Raivich and Kretuzber, 1987) are found in cholinergic neurons in the basal forebrain and neostriatum; the response of these neurons to NGF is well studied. Merlio et al. found t&A mRNA in neurons within the interpeduncular nucleus, the raphe obscurus, the dorsal raphe, and the gigantocellular and paragigantocellular nuclei (Merlio et al., 1992) . Although we did observe trkA expression in scattered neurons in the medullary paramedian reticular formation in the vicinity of known serotonergic neurons, we detected no trkA mRNA and protein in the raphe obscurus and dorsal raphe nuclei. As was true in our studies, Venero and Hefti found trkA mRNA within neurons of the paraventricular anterior and reuniens thalamic nuclei of the thalamus (Venero and Hefti, 1993) . Radiolabeled NGF was reported to bind to neuronal cell bodies in the ventral cochlear nucleus, dorsal nucleus of the lateral lemniscus, the prepositus hypoglossal nucleus, and the medullary reticular formation (Richardson et al., 1986; Raivich and Kretuzber, 1987 ). While we did not find evidence for trkA mRNA in the ventral cochlear nucleus or the dorsal nucleus of the lateral lemniscus, our immunostaining results give evidence that trkA could have mediated NGF binding in these nuclei. Why these regions contained detectable trkA-IR without trkA mRNA is unclear. Conceivably, these cells express trkA mRNA at lower levels than other trkA expressing neurons. If so t&A-IR using the RTA antibody may be a more sensitive method for detecting trkA expression. Further studies will be required to address this point and the response of these neurons to NGE Altar et al. (1991) found NGF binding in the paraventricular nucleus of the thalamus as well as in the "rostra1 and lateral subnuclei of the IPN." Binding in the IPN was attributed to receptors on cholinergic fibers. Our findings show that this binding was probably due in large part to trk.4 expressed on neuronal cell bodies in this region. The relationship between the results of this and earlier studies localizing trkA expression and NGF binding is now more clear; every CNS neuronal group in which trkA mRNA and protein have been detected responds to NGE Both populations of CNS neurons previously identified as NGF-responsive are cholinergic. It is noteworthy that not one of the other trkA expressing populations described herein are known to be cholinergic. The neurotransmitter phenotype of the newly defined trkA expressing neurons is unknown. Indeed in their localization, morphology, and probable connectivity, trkA expressing neurons appear to be quite diverse.
Autophosphorylation of trk on tyrosine is a manifestation of trk kinase activation by neurotrophins. We showed that NGF can rapidly induce the phosphorylation of trk on tyrosine in tissue from both the adult rat septum and ventral midline of the midbrain. Expression of trkA was thus correlated with NGF-signaling. We showed that NGF increased the mean cross-sectional area of trkA-IR neuronal profiles in all t&A-expressing CNS neuronal populations by shifting the normal size distribution of these profiles to the right. While unbiased stereological techniques would be required to document absolute changes in cellular surface area and volume due to NGE such techniques were not necessary to document a treatment effect. This is because the small amount of bias introduced with our methods would be virtually identical for both NGF-and vehicle-treated subjects. An increase in mean cross-sectional area of t&A-IR profiles in all trkA-expressing CNS populations in response to NGF administration strongly suggests that trkA expression not only provides for NGF-signaling but also for a meaningful biological response. Such a response is not uniformly seen in the case of cells expressing trkB and trkC. Kaplan and coworkers have recently shown that mature CNS neurons show little evidence of BDNE NT-3, or NT-4/S signaling in spite of the expression of trkB and t&C (Knusel et al., 1994) . In part, this may be due to expression of truncated forms of trkB that lack the tyrosine kinase domain (Klein et al., 1990; Middlemas et al., 1991) and both truncated and alternative forms of trkC that do not signal (Tsoulfas et al., 1993; Valenzuela et al., 1993) . Certainly for trkB and trkC, evidence of gene expression is insufficient to prove neurotrophin responsiveness. Even in the case of trkA, we would urge caution and suggest that responses to NGF be demonstrated and not simply inferred from data for expression of trkA.
While the localization of trkA mRNA, trkA-IR, and NGF responsiveness were always coincident, only in the basal forebrain, prepositus hypoglossal nucleus, and area postrema was there was a correlation with the expression of ~75~~~ . While it appears under certain conditions that ~75~~~ can modulate NGF-signaling (Lee et al., 1992; Davies et al., 1993; Verdi et al., 1994) , our results suggest that its expression is not required for NGF responsiveness in the CNS. One issue that is raised is whether the affinity of NGF receptors is adequate to transduce a physiologic NGF signal in neurons that do not 200 kD -110 kD-2 3 4 5 6 Figure 7 . NGF stimulates tyrosine phosphorylation of trk. PC12 cells (lanes I and 2), dissociated cells from the rat septum (lanes 3 and 4), and dissociated cells from the ventral midbrain (containing the IPN, lanes 5 and 6) were treated with NGF (100 @ml) (lanes I, 3, and 5) or vehicle (lanes 2, 4, and 6) for 5 min. Cells were then lysed, immunoprecipitated with an anti-pan-trk antibody (1088) followed by antigen blotting with an antibody to phosphotyrosine or RTA. NGF stimulated tyrosine phosphorylation of a 140 kDa protein in PC12 cells. In both the septum and IPN, NGF stimulated tyrosine phosphorylation of a 125 kDa protein. Bands of exactly the same molecular weight as seen with the phosphotyrosine antibody were seen on 1088 immunoprecipitates from PC12 cells or from these brain regions immunoblotted with the trkA specific antibody (RTA). In all lanes, equal amounts of total protein were immunoprecipitated (2.25 mg). Thus, on a per mg/protein basis, the ventral midbrain (containing the IPN) appeared to contain more tyrosine phosphorylated trkA than the septum (containing the medial septal nucleus and vertical limb of the diagonal band).
express ~75 NGFR. NGF concentrations in the CNS are quite low (-0.1-l ng/gm) (Long0 et al., 1992) ; this would seem to require receptors that bind NGF with Kd values in the picomolar range. It is not yet clear whether trkA expression alone creates highaffinity binding (Hempstead et al., 1991) , although there is evidence that this is the case (Jing, et al., 1992) . Interestingly, NGF receptors in the IPN and in the striatum, whose neurons lack detectable ~75~~~~ mRNA and protein Springer et al., 1990; Holtzman et al., 1992b) demonstrate an affinity for NGF in the picomolar range (Richardson et al., 1986; Altar et al., 1991) . Although the function of the trkA expressing neurons described herein has not been defined, the role of these neurons is likely to be very different from that of forebrain cholinergic neurons expressing t&A. Two examples are the IPN and the area postrema. The IPN is thought of as part of the limbic system outflow into the brainstem (Nauta, 1958) , with more recent evidence suggesting ascending influences as well (Vertes and Fass, 1988) . There is also now data suggesting a role for the IPN in sleep, as disruption of the habenulo-interpeduncular pathway alters components of both REM and non-REM sleep in the rat (Haun et al., 1992) . The area postrema has been suggested to be a major center for processing visceral sensory information, to elicit rapid homeostatic responses to fluid and nutrient imbalances (Contreras et al., 1984; Miselis et al., 1986a; Miselis et al., 1986b) . One interesting feature links basal forebrain cholinergic neurons and one of the newly defined NGF-responsive regions. Many studies have shown that basal forebrain cholinergic neurons are particularly vulnerable in Alzheimer's disease (Coyle et al., 1983; Price, 1986; Vogels et al., 1990) . While in general this is not the case for thalamic nuclei, the limbic nuclei in the thalamus, including the paraventricular and reuniens thalamic nuclei, are markedly affected and contain numerous neurofibrillary tangles (Braak and Braak, 1991) . Our results suggest that if NGF is used in the treatment of Aizheimer's disease (Mobley, 1989) , there might be improved function and protection not only of basal forebrain cholinergic neurons but also of vulnerable trkA containing neurons in the limbic thalamus.
